Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Studies Open to Enrollment

Studies Open to Enrollment

Purpose 2 / Lenacapavir Long-acting Investigational PrEP Trial

Hello, Chicagoland!

Project WISH in the Department of Medicine at the University of Illinois Chicago (UIC) is conducting a Phase 3 long-acting investigational PrEP trial. Would you like to volunteer for a 2x/year PrEP injectable trial?

You may qualify. Are you:

  • Currently not on PrEP?
  • 18 years of age or older?
  • Wanting HIV testing, but haven’t done it in 3 months?
  • Bottoming and only sometimes use a condom?
Studies Open to Enrollment
  • Any part of any of the following groups:
    •  Race/Ethnicity
      • American Indian
      • Asian
      • Black
      • Latinx (of any race)
      • Native Hawaiian or Pacific Islander
      • White (if you are transgender/nonbinary or if you identify as Latinx)
      • Mixed ancestry
    • Gender Identity:
      • Cisgender man (of color, Latinx, or of mixed ancestry) who has sex with men
      • Transgender men/women or gender nonbinary individuals (of any race/ethnicity)

For more information about the Gilead lenacapavir investigational trial and how to join, email us at or call us at 312.413.5897. Additionally, you may go to the study website at and/or Clin at learn more about the study, look at reasons to consider participation, and check out the clinical research and study FAQ lists.

UIC Principal Investigator(s):

  • Richard M. Novak, MD (he/him)

Study Coordinator:

  • Diana Bahena (she/her)

Community Affairs Specialist:

  • Charlie Peterson (he/him)